HETEROCYCLIC COMPOUNDS AS PI3 KINASE INHIBITORS
Formula I compounds, including stereoisomers, geometric isomers, tautomers, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting the delta isoform of PI3K, and for treating disorders mediated by lipid kinases such as inflammation, immunological disorders, and cancer....
Saved in:
| Main Authors | , , , , , , |
|---|---|
| Format | Patent |
| Language | English Korean |
| Published |
23.10.2013
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Formula I compounds, including stereoisomers, geometric isomers, tautomers, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting the delta isoform of PI3K, and for treating disorders mediated by lipid kinases such as inflammation, immunological disorders, and cancer. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed. |
|---|---|
| AbstractList | Formula I compounds, including stereoisomers, geometric isomers, tautomers, metabolites and pharmaceutically acceptable salts thereof, are useful for inhibiting the delta isoform of PI3K, and for treating disorders mediated by lipid kinases such as inflammation, immunological disorders, and cancer. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed. |
| Author | PRICE STEPHEN WASZKOWYCZ BOHDAN SEWARD EILEEN M HEALD ROBERT SUTHERLIN DANIEL P SAFINA BRIAN SAVY PASCAL PIERRE ALEXANDRE |
| Author_xml | – fullname: SAFINA BRIAN – fullname: SUTHERLIN DANIEL P – fullname: PRICE STEPHEN – fullname: SEWARD EILEEN M – fullname: SAVY PASCAL PIERRE ALEXANDRE – fullname: WASZKOWYCZ BOHDAN – fullname: HEALD ROBERT |
| BookMark | eNrjYmDJy89L5WTQ93ANcQ3yd4509vF0VnD29w3wD_VzCVZwDFYI8DRW8Pb0cwx2VfD08_B08gzxDwrmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx3kFGBobGBoaGZsamFo7GxKkCAJuJKJg |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | KR20130116358A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_KR20130116358A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 13:55:24 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English Korean |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_KR20130116358A3 |
| Notes | Application Number: KR20137023000 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131023&DB=EPODOC&CC=KR&NR=20130116358A |
| ParticipantIDs | epo_espacenet_KR20130116358A |
| PublicationCentury | 2000 |
| PublicationDate | 20131023 |
| PublicationDateYYYYMMDD | 2013-10-23 |
| PublicationDate_xml | – month: 10 year: 2013 text: 20131023 day: 23 |
| PublicationDecade | 2010 |
| PublicationYear | 2013 |
| RelatedCompanies | F. HOFFMANN-LA ROCHE AG |
| RelatedCompanies_xml | – name: F. HOFFMANN-LA ROCHE AG |
| Score | 2.8727086 |
| Snippet | Formula I compounds, including stereoisomers, geometric isomers, tautomers, metabolites and pharmaceutically acceptable salts thereof, are useful for... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | HETEROCYCLIC COMPOUNDS AS PI3 KINASE INHIBITORS |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20131023&DB=EPODOC&locale=&CC=KR&NR=20130116358A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT4MwEL_MadQ3nRo_piHR8Ebm1pbBAzFQIOAcEGBmPi2UQGI0sDiM_74t2XRPe2t7yfUj-d1Hr3cFeCgyUnLFipVcxbqCGXtUMkaIgnINYZINc70UjuI0UL0Zfp6TeQc-N7kwbZ3Qn7Y4IkdUzvHetPJ6-X-JZbdvK1cD9s6H6ic3NWx57R0PkahEINuW4UShHVKZUmMSy0Hc0kTMARHN3IN9bkiPBR6cV0vkpSy3lYp7AgcR51c1p9D5qHtwRDd_r_XgcLoOefPmGn2rMxh4Djc-Q_pGX3wq0XAahbPATiQzkSIfSdwRNxNH8gPPt_w0jJNzuHedlHoKn3nxt9HFJN5eJrqAblVXxSVIQ0aYzpBG8lGGsa5mpNDLUsvGSC1xqeVX0N_F6Xo3-QaORVdI5BHqQ7f5-i5uuapt2F17Qr_z03ym |
| link.rule.ids | 230,309,783,888,25576,76882 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFetNq-KjakDJLdR2d2NyKNJuUhLzJEmlnkI2JCBKWmzEv-9uaLWn3pb9YPYB89rZmQF4KDJScsWKlVzFuoIZe1QyRoiCcg1hkg1yvRSOouer1gy_zMm8BZ-bXJimTuhPUxyRc1TO-b1u5PXy_xHLaP5WrvrsnU8tnqfJyJDX3vEAiUoEsjEZmWFgBFSmdOREsh81mIg5IKKN92CfG9ma6Hdgvk5EXspyW6lMj-Eg5PSq-gRaH4sudOim91oXDr11yJsP19y3OoW-ZXLjM6Bv1LWpRAMvDGa-EUvjWAptJHFHfBybku1b9sROgig-g_upmVBL4SunfwdNnWh7m-gc2tWiKi5AGjDCdIY0kg8zjHU1I4Vellr2hNQSl1p-Cb1dlK52w3fQsRLPTV3bd67hSEBCOg9RD9r113dxw9VuzW6b2_oF9Ed_lg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HETEROCYCLIC+COMPOUNDS+AS+PI3+KINASE+INHIBITORS&rft.inventor=SAFINA+BRIAN&rft.inventor=SUTHERLIN+DANIEL+P&rft.inventor=PRICE+STEPHEN&rft.inventor=SEWARD+EILEEN+M&rft.inventor=SAVY+PASCAL+PIERRE+ALEXANDRE&rft.inventor=WASZKOWYCZ+BOHDAN&rft.inventor=HEALD+ROBERT&rft.date=2013-10-23&rft.externalDBID=A&rft.externalDocID=KR20130116358A |